Skip to main content

Table 2 Multivariate logistic regression model for outcomes

From: Comparisons of outcomes in stroke subtypes after intravenous thrombolysis

 

Favorable outcome

Good outcome

Symptomatic ICH

Any hemorrhage

Mortality

Odds ratio

p

Odds ratio

p

Odds ratio

p

Odds ratio

p

Odds ratio

p

TOAST

 

0.037

 

0.080

 

0.503

 

0.003

  

 LAA versus SVD

0.39 (0.18–0.69)

0.005

0.46 (0.23–0.83)

0.011

2.50 (0.27–23.7)

0.423

11.03 (2.51–48.6)

0.002

  

 CE versus SVD

0.69 (0.28–1.70)

0.415

0.73 (0.30–1.78)

0.482

5.60 (0.54–58.5)

0.150

12.26 (2.43–61.9)

0.003

  

 UnD versus SVD

0.53 (0.28–1.03)

0.059

0.60 (0.31–1.14)

0.118

3.84 (0.42–35.2)

0.234

6.07 (1.31–28.1)

0.021

  

 CE versus LAA

1.76 (0.72–4.29)

0.215

1.67 (0.70–3.96)

0.248

2.24 (0.49–10.2)

0.297

1.11 (0.46–2.72)

0.816

  

Initial NIHSS

0.92 (0.89–0.96)

<0.001

0.91 (0.88–0.95)

<0.001

1.08 (1.02–1.14)

0.007

1.03 (0.995–1.07)

0.091

1.13 (1.07–1.20)

<0.001

Age

0.98 (0.96–0.999)

0.043

0.99 (0.97–1.00)

0.088

1.02 (0.98–1.05)

0.330

  

1.04 (0.99–1.08)

0.111

Sex (male)

1.54 (0.92–2.57)

0.098

1.31 (0.80–2.14)

0.281

0.50 (0.23–1.10)

0.083

  

0.47 (0.19–1.16)

0.101

Atrial fibrillation

0.94 (0.44–2.00)

0.862

0.68 (0.32–1.42)

0.300

0.93 (0.28–3.12)

0.906

1.29 (0.59–2.81)

0.526

1.33 (0.50–3.55)

0.572

Hyperlipidemia

    

0.69 (0.30–1.60)

0.385

  

0.13 (0.03–0.59)

0.008

Smoking

1.36 (0.81–2.27)

0.247

1.39 (0.84–2.31)

0.199

      

Prior anticoagulant treatment

      

1.92 (0.60–6.09)

0.270

3.78 (0.71–20.1)

0.119

Congestive heart failure

        

1.31 (0.31–5.51)

0.714

  1. Baseline variables with a p value <0.1 in univariate analysis were included in multivariate logistic regression models for each outcome. Favorable and good outcomes: TOAST classification, initial NIHSS, age, sex, atrial fibrillation and smoking; symptomatic ICH: TOAST classification, initial NIHSS, age, sex, atrial fibrillation and hyperlipidemia; any hemorrhage: TOAST classification, initial NIHSS, atrial fibrillation and prior anticoagulant treatment; mortality: initial NIHSS, age, sex, atrial fibrillation, hyperlipidemia, prior anticoagulant treatment and congestive heart failure